'Olive oil' drug shows early promise for some brain cancer patients 21 Feb 2024 A unique drug derived from oleic acid – which naturally occurs in animal and vegetable fats such as olive oil – has shown promise for patients with an advanced form of the most common type of brain cancer, following a study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. Find out more Show/Hide
AACR 2022: New 'killer' immunotherapy shows early promise in range of solid tumours 08 Apr 2022 A new type of immunotherapy making use of the immune system’s ‘natural killer cells’ could offer potential against a range of cancers that can evade current treatments, early results from a phase I trial suggest. Find out more Show/Hide
ASCO 2021: Early promise for first targeted brain cancer treatment 20 Jun 2021 A new drug could become the first ever targeted brain cancer treatment, with encouraging early results from a phase 1 trial suggesting it could treat some patients with advanced disease. Find out more Show/Hide
AACR Annual Meeting 2021: Immunotherapy combination shows early promise in aggressive brain cancers 11 Apr 2021